MISSION® esiRNA
SIGMA/EHU065921 - targeting human PRMT5
Product Type: Product-on-demand
| description | Powered by Eupheria Biotech |
| Ensembl | human accession no. | ENSG00000100462 ![]() |
| esiRNA cDNA target sequence | TGCAGTGGCTCTTGAAATTGGGGCT |
| form | lyophilized powder |
| NCBI accession no. | NM_006109 ![]() |
| product line | MISSION® |
| Quality Level | 100 ![]() |
| shipped in | ambient |
| storage temp. | −20°C |
| Biochem/physiol Actions: | PRMTs (protein arginine N-methyltransferases) are responsible for the methylation of arginine residues in histones. PRMT5 causes monomethylation and symmetric dimethylation reactions. It works as an oncogene is some neoplasms and is associated with cell proliferation, inhibition of cell death and regulation of tumor suppressor genes. PRMT5 is also involved in stem cell maintenance by controlling differentiation-associate |
| General description: | MISSION® esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence. These multiple silencing triggers lead to highly-specific and effective gene silencing. For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA . |
| Legal Information: | MISSION is a registered trademark of Merck KGaA, Darmstadt, Germany |
| RIDADR | NONH for all modes of transport |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Storage Temp. | −20°C |
| UNSPSC | 41105324 |

